268 related articles for article (PubMed ID: 24993315)
1. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of GATA3 and p40 immunostains in the diagnosis of metastatic urothelial carcinoma in cytology specimens.
Brandler TC; Aziz MS; Rosen LM; Bhuiya TA; Yaskiv O
Cancer Cytopathol; 2014 Jun; 122(6):468-73. PubMed ID: 24711443
[TBL] [Abstract][Full Text] [Related]
3. Urine cytomorphology of micropapillary urothelial carcinoma.
Zhu B; Rohan SM; Lin X
Diagn Cytopathol; 2013 Jun; 41(6):485-91. PubMed ID: 22623512
[TBL] [Abstract][Full Text] [Related]
4. Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.
Zinnall U; Weyerer V; Compérat E; Camparo P; Gaisa NT; Knuechel-Clarke R; Perren A; Lugli A; Toma M; Baretton G; Kristiansen G; Wirtz RM; Cheng L; Wullich B; Stoehr R; Hartmann A; Bertz S
Hum Pathol; 2018 Oct; 80():55-64. PubMed ID: 29885409
[TBL] [Abstract][Full Text] [Related]
5. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion in micropapillary urothelial carcinoma: a study of 22 cases.
McQuitty E; Ro JY; Truong LD; Shen SS; Zhai Q; Ayala AG
Arch Pathol Lab Med; 2012 Jun; 136(6):635-9. PubMed ID: 22646270
[TBL] [Abstract][Full Text] [Related]
7. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
8. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
[TBL] [Abstract][Full Text] [Related]
9. Pleural fluid metastasis of plasmacytoid urothelial carcinoma in comparison to micropapillary and conventional high-grade urothelial carcinoma: Cytologic and immuonohistochemical findings.
Wang BG; Woodward K; Menezes G; Wang ZQ; He R; Li W
Diagn Cytopathol; 2022 Sep; 50(9):E248-E254. PubMed ID: 35560555
[TBL] [Abstract][Full Text] [Related]
10. Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.
Hoang LL; Tacha D; Bremer RE; Haas TS; Cheng L
Appl Immunohistochem Mol Morphol; 2015; 23(10):711-6. PubMed ID: 25611245
[TBL] [Abstract][Full Text] [Related]
11. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
Esheba GE; Longacre TA; Atkins KA; Higgins JP
Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
[TBL] [Abstract][Full Text] [Related]
12. Comparison of tyrosine kinase receptors HER2, EGFR, and VEGFR expression in micropapillary urothelial carcinoma with invasive urothelial carcinoma.
Li J; Jackson CL; Yang D; Noble L; Wheeler M; MacKenzie D; Adegun T; Amin A
Target Oncol; 2015 Sep; 10(3):355-63. PubMed ID: 25293577
[TBL] [Abstract][Full Text] [Related]
13. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.
Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS
Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175
[TBL] [Abstract][Full Text] [Related]
14. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases.
Amin A; Epstein JI
Hum Pathol; 2012 Dec; 43(12):2124-8. PubMed ID: 22939957
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
[TBL] [Abstract][Full Text] [Related]
18. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
19. Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study.
Mai KT; Hakim SW; Ball CG; Flood TA; Belanger EC
Pathol Int; 2014 Aug; 64(8):375-81. PubMed ID: 25143125
[TBL] [Abstract][Full Text] [Related]
20. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder.
Fatima N; Osunkoya AO
Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
